ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System

An Interview Series with Members of the ASHP Expert Panel on Formulary Management: Part 3: Sabrina W. Cole, PharmD.

This article presents the third in a series of three interviews that P&T conducted with several members of the American Society of Health-System Pharmacists (ASHP) Expert Panel on Formulary Management.In 2008, ASHP convened this panel of experts to develop revised guidelines for P&T committee and formulary management to replace the previous guidance issued in 1991.1 These revised guidelines inc...

ASHP guidelines on the pharmacy and therapeutics committee and the formulary system.

Purpose These guidelines outline the recommended processes and techniques for formulary system management and describe the pharmacist's responsibilities and roles in managing the formulary system in partnership with other health care professionals. These guidelines also provide assistance to pharmacists in the organization and operation of the pharmacy and therapeutics (P&T) committee or equiva...

ASHP statement on the formulary system.

The care of patients in hospitals and other health-care facilities is often dependent on the effective use of drugs. The multiplicity of drugs available makes it mandatory that a sound program of drug usage be developed within the institution to ensure that patients receive the best possible care. In the interest of better patient care, the institution should have a program of objective evaluat...

ASHP statement on the pharmacy and therapeutics committee.

ASHP guidelines for pharmacists on the activities of vendors' representatives in organized health care systems. American Society of Hospital Pharmacists.

For purposes of this document, vendors’ representatives are defined as agents who promote products and provide information and services to health care providers on behalf of manufacturers and suppliers. The narrow focus of this document is on those vendors who serve and interact with settings with respect to drug products, drug-related devices, and other equipment, supplies, and services purcha...